Quarterly Results

  • Company Name :
Glenmark Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532296
  • NSE Symbol:
  • GLENMARK
  • P/E(TTM):
  • 22.24
  • ISIN Demat:
  • INE935A01035
  • Div & Yield%:
  • 0.17
  • EPS(TTM):
  • 67.15
  • Book Value(₹):
  • 848.60
  • Market Cap(₹Cr.):
  • 42,147.62
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2024 ( Cr)June 2024 ( Cr)March 2024 ( Cr)
Gross Sales 2,594.89 2,296.88 2,077.13
Excise Duty 0.00 0.00 0.00
Net Sales 2,594.89 2,296.88 2,077.13
Other Operating Income 41.21 32.66 71.09
Other Income 83.08 55.65 5,933.18
Total Income 2,719.18 2,385.19 8,081.41
Total Expenditure 1,857.47 1,698.44 1,650.78
PBIDT 861.70 686.75 6,430.63
Interest 11.80 15.35 83.39
PBDT 849.91 671.40 6,347.25
Depreciation 54.85 53.09 52.40
Tax 138.46 107.98 1,055.38
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 61.54 56.60 625.77
Reported Profit After Tax 595.06 453.73 4,613.70
Extra-ordinary Items 0.00 0.00 3,772.34
Adjusted Profit After Extra-ordinary item 595.06 453.73 841.36
EPS (Unit Curr.) 21.09 16.08 163.50
EPS (Adj) (Unit Curr.) 21.09 16.08 163.50
Calculated EPS (Unit Curr.) 21.09 16.08 163.50
Calculated EPS (Adj) (Unit Curr.) 21.09 16.08 163.50
Calculated EPS (Ann.) (Unit Curr.) 84.35 64.32 653.98
Calculated EPS (Adj) (Ann.) (Unit Curr.) 84.35 64.32 653.98
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 28.22 28.22 28.22
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 33.21 29.90 309.59
PBDTM(%) 32.75 29.23 305.58
PATM(%) 22.93 19.75 222.12